Skip to content

Nutritional Aspects in Head and Neck Cancer Patients undergoing Radio(chemo)therapy

Nutritional Aspects in Head and Neck Cancer Patients undergoing Radio(chemo)therapy - Head-Nut-Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016862
Enrollment
70
Registered
2019-03-11
Start date
2018-11-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C14 R64

Interventions

Group 1: Interventional group - (intensified) nutritional counseling unter radio(chemo)therapy Group 2: Control group - no nutritional counseling under ongoing radio(chemo)therapy

Sponsors

Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: - Patients who undergo curative radio(chemo)therapy at the Department of Radiotherapy and Radiooncology of the University Medical Center Hamburg-Eppendorf (and/or its outpatient center) due to head and neck cancer - Patients who are at least 18 years old

Exclusion criteria

Exclusion criteria: - Pregnancy - Patients who are not able sign written informed consent - Patients with a cardiac defibrillator

Design outcomes

Primary

MeasureTime frame
Primary endpoints include the assessment of phase angle from bioelectric impedance measurements as an indicator for malnutrition. Also, we want to examine whether there is a difference in phase angle between our control and our interventional group.

Secondary

MeasureTime frame
Secondary endpoints include therapy-related toxicity, thus implying that patients undergoing an intensified dietary and nutritional counseling present with less therapy-related side effects (according to CTCAE-criteria). Also, assessment of quality of life in both groups (control and interventional group) and outcome factors including survival rates are to be examined.

Countries

Germany

Contacts

Public ContactAnastassia Löser

Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikums Hamburg-Eppendorf / Ambulanzzentrum des UKE GmbH (Fachbereich: Strahlentherapie)

an.loeser@uke.de+49 (0)40-7410-53832

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026